LaVoieHealthScience Awarded Best Pharma Product Launch at 2024 PRWeek ...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 15, 2024

Texas Woman Sues Mexican Resort for Hot Tub Electrocution That Killed Husband • Healthfirst and Community Partners Host Father’s Day Celebration and Raise Awareness about Men’s Health Issues • Statement by Minister Khera on Eid al-Adha • Federal Home Loan Bank of Dallas and Texas Capital Award $850K for Austin Affordable Housing • LUDWIG+ Named Small Agency of the Year by the Association of National Advertisers • Franklin Templeton Completes Reorganization of ClearBridge All Cap Growth ESG ETF (CACG) into ClearBridge Large Cap Growth ESG E • Statement by the Prime Minister on Eid al-Adha • Here Media Sets June 14th Exclusive Season 2 Premiere of Lamont Pierre's Award-Winning Original Series 'A Beautiful Cruel Thing' • ŌURA Helping Millions of People Improve Their Health, Surpasses 2.5 Million Rings Sold • DoubleVerify: MFA Impression Volume Increases by 19% Year-Over-Year Fueled By AI Advances • Eid Al Ad'ha Unity Outdoor Prayer for Gaza in Dearborn • Ministers O'Regan and Saks mark World Elder Abuse Awareness Day • YWCA Greater Los Angeles Welcomes Lisa Hirsch Marin as Chief Program Officer • NATIONAL HISPANIC MEDIA COALITION HONORS LAFC WITH COMMUNITY IMPACT AWARD • Chegg Reports New Hire Equity Grants Under NYSE Rule 303A.08 • Georgia Safe Retirement Planners Opens New Office in Roswell, GA • CapitaLand Investment Further Increases Focus on Reducing Scope 3 Carbon Emissions as Part of its Decarbonisation Journey • AGWA and Believer Meats to Develop Cultivated Meat Capabilities in Abu Dhabi • VyStar Foundation Awards Grants to 12 Military and Veterans Nonprofits • New York Times Bestselling Authors Bill Martin Jr and Michael Sampson Publish Children’s Picture Book Perfect for Father&r

LaVoieHealthScience Awarded Best Pharma Product Launch at 2024 PRWeek Healthcare Awards

BOSTON & NEW YORK , May 22 /Businesswire/ - LaVoieHealthScience (LHS) is honored to be awarded with the prestigious title of "Best Pharma Product Launch (Non-OTC)” at this year’s PRWeek Healthcare Awards on May 21. This award is for the partnership with Menarini Stemline from the 2023 launch of ORSERDU® (elacestrant) for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.

The award-winning product launch, which focused on increasing visibility and on-label education of ORSERDU®, the first oral selective estrogen receptor modulator (SERD), approved for marketing in the US in January 2023. The combined teams’ communication efforts highlight the impactful collaboration between Menarini Stemline and LaVoieHealthScience.

Donna L. LaVoie, President and CEO of LaVoieHealthScience, expressed her gratitude and pride in the teams’ achievement: "We are immensely proud of our team's hard work and dedication to the 'why' behind this important project. This recognition from PRWeek Healthcare Awards underscores our commitment to excellence in healthcare communications and our dedication to improving patient outcomes. Our commercial practice PR account team, both past and present, played an important role in bringing the first endocrine innovation in 20 years, addressing ESR1 mutations, a major unmet need.”

The PRWeek Healthcare Awards is renowned for celebrating the best of the best in healthcare public relations, recognizing firms that drive the industry forward through innovative and creative strategies.

LaVoieHealthScience extends its thanks to the team at Menarini Stemline for entrusting us with the opportunity to be part of such significant and impactful work. This award is a shared success, reflecting the synergy and collaboration between our organizations. Read our case study with Menarini Stemline here.

About LaVoieHealthScience

LaVoieHealthScience partners with health and science emerging and commercial organizations to advance their innovations. The complexity of the business of science, medicine, and technology requires leaders to create a unique voice in a highly regulated industry. We guide leaders using our 20+ years of history with modern perspectives and time-tested results. Our programs include strategic positioning, public relations and marketing, investor relations, corporate communications, and digital and creative services. For more information, please visit lavoiehealthscience.com and connect with us on LinkedIn, X, Facebook.